Frequently Asked Questions about Labcorp Holdings Inc. (LH)

Name: Labcorp Holdings Inc. (LH) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Labcorp Holdings Inc. (LH) do?

Accepted Answer

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC....

Question 2

Is Labcorp Holdings Inc. (LH) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of LH reveals an Altman Z-Score of 3.14 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($13.95B most recent), help investors decide if LH fits their risk profile.

Question 3

What is the current P/E ratio for LH?

Accepted Answer

As of the latest trading session, Labcorp Holdings Inc. (LH) has a trailing P/E ratio of 24.72.

Question 4

Who is the CEO of Labcorp Holdings Inc.?

Accepted Answer

The current Chief Executive Officer of Labcorp Holdings Inc. is Adam H. Schechter.

Question 5

What was LH's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Labcorp Holdings Inc. reported annual revenues of $13.95B (2025), $13.01B (2024), $12.16B (2023), $11.86B (2022), $13.14B (2021) respectively.

Question 6

Does LH pay a dividend?

Accepted Answer

Labcorp Holdings Inc. currently pays a dividend to its shareholders, with a trailing dividend yield of 1.10%.

Question 7

How much debt and cash flow does LH have?

Accepted Answer

In its latest reporting period, Labcorp Holdings Inc. generated $1.21B in Free Cash Flow against a total debt load of $7.20B.

Question 8

What is the Price-to-Book (P/B) ratio of Labcorp Holdings Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Labcorp Holdings Inc. (LH) is currently 2.51.

Question 9

What is the Price-to-Sales (P/S) ratio of LH?

Accepted Answer

Based on trailing twelve-month data, Labcorp Holdings Inc. (LH) trades at a Price-to-Sales (P/S) ratio of 1.56.

Question 10

What is Labcorp Holdings Inc.'s Return on Equity (ROE)?

Accepted Answer

Labcorp Holdings Inc. (LH) has a Return on Equity (ROE) of 10.28%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	1.6B	125.8M	-434.5M	1.2B	1.1B
2024-12	1.6B	116.7M	-489.9M	1.1B	979.2M
2023-12	1.3B	128.7M	-453.6M	874.1M	745.4M
2022-12	2B	116.8M	-481.9M	1.5B	1.4B
2021-12	3.1B	132.9M	-460.4M	2.6B	2.5B

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	1.6B	125.8M	-434.5M	1.2B	1.1B
2024-12	1.6B	116.7M	-489.9M	1.1B	979.2M
2023-12	1.3B	128.7M	-453.6M	874.1M	745.4M
2022-12	2B	116.8M	-481.9M	1.5B	1.4B
2021-12	3.1B	132.9M	-460.4M	2.6B	2.5B